ARTICLE | Clinical News
Zykadia ceritinib regulatory update
May 18, 2015 7:00 AM UTC
The European Commission approved Zykadia ceritinib from Novartis to treat advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in adults previously treated with Xalk...